Literature DB >> 26688113

Differentiation of rodent behavioral phenotypes and methylphenidate action in sustained and flexible attention tasks.

Richard Chu1, Jed Shumsky1, Barry D Waterhouse2.   

Abstract

Methyphenidate (MPH) is the primary drug treatment of choice for ADHD. It is also frequently used off-label as a cognitive enhancer by otherwise healthy individuals from all age groups and walks of life. Military personnel, students, and health professionals use MPH illicitly to increase attention and improve workplace performance over extended periods of work activity. Despite the frequency of its use, the efficacy of MPH to enhance cognitive function across individuals and in a variety of circumstances is not well characterized. We sought to better understand MPH׳s cognitive enhancing properties in two different rodent models of attention. We found that MPH could enhance performance in a sustained attention task, but that its effects in this test were subject dependent. More specifically, MPH increased attention in low baseline performing rats but had little to no effect on high performing rats. MPH exerted a similar subject specific effect in a test of flexible attention, i.e. the attention set shifting task. In this test MPH increased behavioral flexibility in animals with poor flexibility but impaired performance in more flexible animals. Overall, our results indicate that the effects of MPH are subject-specific and depend on the baseline level of performance. Furthermore, good performance in in the sustained attention task was correlated with good performance in the flexible attention task; i.e. animals with better vigilance exhibited greater behavioral flexibility. The findings are discussed in terms of potential neurobiological substrates, in particular noradrenergic mechanisms, that might underlie subject specific performance and subject specific responses to MPH. This article is part of a Special Issue entitled SI: Noradrenergic System.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Behavioral phenotype; Flexible attention; Psychostimulant; Sustained attention

Mesh:

Substances:

Year:  2015        PMID: 26688113      PMCID: PMC5127589          DOI: 10.1016/j.brainres.2015.11.039

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  63 in total

1.  In vivo comparison of norepinephrine and dopamine release in rat brain by simultaneous measurements with fast-scan cyclic voltammetry.

Authors:  Jinwoo Park; Pavel Takmakov; R Mark Wightman
Journal:  J Neurochem       Date:  2011-10-20       Impact factor: 5.372

2.  Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability.

Authors:  M D S Lapiz; D A Morilak
Journal:  Neuroscience       Date:  2005-11-17       Impact factor: 3.590

3.  The NH(2)-terminus of norepinephrine transporter contains a basolateral localization signal for epithelial cells.

Authors:  H H Gu; X Wu; B Giros; M G Caron; M J Caplan; G Rudnick
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

4.  Executive impairment determines ADHD medication response: implications for academic achievement.

Authors:  James B Hale; Linda A Reddy; Margaret Semrud-Clikeman; Lisa A Hain; James Whitaker; Jessica Morley; Kyle Lawrence; Alex Smith; Nicole Jones
Journal:  J Learn Disabil       Date:  2011 Mar-Apr

5.  Neuropsychological function in adults with attention-deficit hyperactivity disorder.

Authors:  L J Seidman; J Biederman; W Weber; M Hatch; S V Faraone
Journal:  Biol Psychiatry       Date:  1998-08-15       Impact factor: 13.382

6.  Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity.

Authors:  J Swanson; M Kinsbourne; W Roberts; K Zucker
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

7.  Dissociation between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats in baseline performance and methylphenidate response on measures of attention, impulsivity and hyperactivity in a Visual Stimulus Position Discrimination Task.

Authors:  Panayotis K Thanos; Iliyan Ivanov; John K Robinson; Michael Michaelides; Gene-Jack Wang; James M Swanson; Jeffrey H Newcorn; Nora D Volkow
Journal:  Pharmacol Biochem Behav       Date:  2009-10-08       Impact factor: 3.533

8.  A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters.

Authors:  Maureen K Hahn; David Robertson; Randy D Blakely
Journal:  J Neurosci       Date:  2003-06-01       Impact factor: 6.167

9.  Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity.

Authors:  Mitul A Mehta; Ian M Goodyer; Barbara J Sahakian
Journal:  J Child Psychol Psychiatry       Date:  2004-02       Impact factor: 8.982

10.  Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.

Authors:  Dawn D Han; Howard H Gu
Journal:  BMC Pharmacol       Date:  2006-03-03
View more
  3 in total

1.  Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attention.

Authors:  Courtney A Marshall; Zachary D Brodnik; Ole V Mortensen; Maarten E A Reith; Jed S Shumsky; Barry D Waterhouse; Rodrigo A España; Sandhya Kortagere
Journal:  Neuropharmacology       Date:  2019-01-08       Impact factor: 5.250

Review 2.  Linking ADHD to the Neural Circuitry of Attention.

Authors:  Adrienne Mueller; David S Hong; Steven Shepard; Tirin Moore
Journal:  Trends Cogn Sci       Date:  2017-05-05       Impact factor: 20.229

3.  Baseline-dependent effects of amphetamine on attention are associated with striatal dopamine metabolism.

Authors:  Karly M Turner; James Peak; Thomas H J Burne
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.